FDA Inspection 1171209 — Ashley Efrain Alarcon Rozas
The FDA completed an inspection of Ashley Efrain Alarcon Rozas on May 13, 2022 in Lima. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 13, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lima (Peru)
Additional Details
Clinical Investigator (CI)